学术动态-en The clinical research standards for P53 restorer proposed by the research group in 2025 were published in Nat Rev Cancer 2025年5月27日
学术动态-en Researcher Lu Min served as the executive chair of the Youth Forum at the 18th National Congress of Experimental Hematology and delivered a keynote speech on “Targeting the Tumor Suppressor Protein p53.” 2025年5月17日
学术动态-en The research results of the research group have been highly praised by many senior experts from the fields of structure, clinical medicine, and small molecule of traditional Chinese medicine in the journal “Chemistry of Life”. It is considered a rare and domestically independent intellectual property innovation at the grassroots level 2025年5月17日
学术动态-en Tang Yigang, a member of Lu Min’s research group, completed the defense of his doctoral thesis 2025年5月16日
学术动态-en The research results of the Life Time Research Group on arsenic trioxide restoring the anti-cancer function of p53 structural mutant have been highly praised by Nature Reviews Cancer 2025年5月16日
学术动态-en Basic research and clinical translation of p53 targeting small molecules – [sponsored by Hua’an Biotechnology] BioArt and One Work Face to Face (Oncology, Issue 2) 2025年5月16日
学术动态-en In 2024, Professor Lu Min, the leader of the research group, was awarded the Youth Science Foundation Project (Class A) 2025年1月1日